n(2)-(gamma-d-glutamyl)-meso-2,2'-diaminopimelic acid has been researched along with lactic acid in 2 studies
| Studies (n(2)-(gamma-d-glutamyl)-meso-2,2'-diaminopimelic acid) | Trials (n(2)-(gamma-d-glutamyl)-meso-2,2'-diaminopimelic acid) | Recent Studies (post-2010) (n(2)-(gamma-d-glutamyl)-meso-2,2'-diaminopimelic acid) | Studies (lactic acid) | Trials (lactic acid) | Recent Studies (post-2010) (lactic acid) |
|---|---|---|---|---|---|
| 46 | 1 | 39 | 46,263 | 3,349 | 19,053 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frentsch, M; Lendlein, A; Mathew, S; Roch, T; Wischke, C | 2 |
2 other study(ies) available for n(2)-(gamma-d-glutamyl)-meso-2,2'-diaminopimelic acid and lactic acid
| Article | Year |
|---|---|
Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Cell Line, Tumor; Cell Survival; Cytokines; Dendritic Cells; Diaminopimelic Acid; Drug Carriers; Drug Compounding; Humans; Lactic Acid; Leukocytes, Mononuclear; Ligands; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Vaccines | 2012 |
Adjuvant effect of microencapsulated NOD ligands studied in a human phagocytic cell line.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Cell Line; Diaminopimelic Acid; Drug Compounding; Emulsions; Humans; Lactic Acid; Ligands; Microspheres; Nod Signaling Adaptor Proteins; Oils; Phagocytes; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vaccines, Subunit; Water | 2012 |